Obiltoxaximab is a monoclonal antibody targeting the free protective antigen (PA) of Bacillus anthracis, used for the treatment of inhalational anthrax caused by Bacillus anthracis.
Purity:
95%
CAS Number:
[1351337-07-9]
Target:
Antibacterial
* VAT and and shipping costs not included. Errors and price changes excepted